Study Details
Full Title
A Phase 1b/2 Study Evaluating the Activity of Tinengotinib (TT-00420) in Combination with Androgen Receptor Signaling Inhibitors (ARSIs) in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Principal Investigator
Hannah
McManus
Protocol Number
PRO00116180
NCT ID
NCT06457919
Phase
I/II
Enrollment Status
Open to Enrollment